Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Recruiting · NCT06026163 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Respiration Disorders, Urogenital Diseases, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, pregnancy disorder, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2025-06-27 | NCT06026163 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ministry of Health, Saudi Arabia | 7 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King Salman Bin Abdulaziz Medical City | Madinah | Saudi Arabia | 1 |
| King Salman Bin Abdulaziz Medical City | Madinah | Saudi Arabia | 2 |